Shawn Tomasello, Director at 4D Molecular Therapeutics, holds ― shares in 4D Molecular Therapeutics (Ticker: FDMT), holds 22.73K shares in Cabaletta Bio (Ticker: CABA), holds 70.00K shares in Kalaris Therapeutics (Ticker: KLRS). Most recently, Shawn Tomasello ― shares of 4D Molecular Therapeutics on ― for an estimated value of ―.
Shawn Tomasello latest transaction was an Uninformative Buy of ―.
What was Shawn Tomasello's most profitable transaction?
Shawn Tomasello’s most profitable transaction was an Informative Sell of DPLO stock on June 5, 2018. The return on the trade was 81.10%.
What is Shawn Tomasello's role in 4D Molecular Therapeutics?
Shawn Tomasello's role in 4D Molecular Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.